AACE MENA 2025-Metabolic and Bariatric Management in Pediatrics

Video Transcription

Video Summary

The speaker addresses the growing global challenge of childhood obesity, highlighting alarming statistics with over 41 million affected children under five and over 340 million youths worldwide. She emphasizes obesity's complex, multifactorial causes, including genetics and environment, and its severe comorbidities such as type 2 diabetes, hypertension, and psychological impacts evident even in children. Discussing treatments, she reviews pharmacological options approved for adolescents, including orlistat, phentermine, topiramate, and notably GLP-1 receptor agonists like liraglutide and semaglutide, while acknowledging issues with medication reimbursement. The talk covers digital interventions that aid weight management and focuses on bariatric surgery as an increasingly accepted, effective option for severe pediatric obesity cases resistant to other treatments. Lastly, she highlights rare monogenic obesity forms treatable with novel drugs like setmelanotide. The presentation concludes with a call for multidisciplinary approaches, better insurance support, and preparedness for pediatric obesity transitioning into adulthood.

Meta Tag

Concept Pediatric Obesity

Concept Comorbidity

Concept Insulin Resistance

Concept Type 2 Diabetes

Concept Monogenic Obesity

Keywords

childhood obesity

pediatric weight management

GLP-1 receptor agonists

bariatric surgery

monogenic obesity

multidisciplinary treatment

Pediatric Obesity

Comorbidity

Insulin Resistance

Type 2 Diabetes

Monogenic Obesity